FDA considers major shift in COVID vaccine strategy

The Food and Drug Administration is considering a major shift in the nation's COVID-19 vaccine strategy.

The goal is to simplify vaccination against COVID and perhaps adopt an approach similar that used for the flu vaccine, with annual updates to match whatever strain of the virus is circulating. This is according to a federal official who spoke under the condition of anonymity because they were not authorized to speak publicly.